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Exposome research can improve the understanding of the mechanistic connections
between exposures and health to help mitigate adverse health outcomes across the
life span. The exposomic approach provides a risk profile instead of single predictors
and thus is particularly applicable to allergic diseases and asthma. Under the PRAC-
TALL collaboration between the European Academy of Allergy and Clinical
Immunology (EAACI) and the American Academy of Allergy, Asthma, and Immunol-
ogy (AAAAI), we evaluated the current concepts and the unmet needs on the role
of the exposome in allergic diseases and asthma.
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1 | INTRODUCTION
This consensus document summarizes the current knowledge on the
role of the exposome in allergic diseases and asthma under the aus-
pices of the PRACTALL collaboration platform. PRACTALL is an ini-
tiative of the European Academy of Allergy and Clinical Immunology
(EAACI) and the American Academy of Allergy, Asthma, and Immu-
nology (AAAAI) aiming to harmonize the European and the American
approach to improve the allergy practice and science.
This PRACTALL document addresses several key questions:
1. How is the exposome altering the biology to promote allergies/
asthma?
2. What is the relevance of the exposome for allergy and asthma
evolution?
3. What is the relevance of gaps, priority research needs and
opportunities?
4. What is the relevance of the exposome data to clinical practice
and to policy advocates?
2 | FRAMING THE ISSUE
2.1 | The domains of the exposome relevant to
allergic diseases and asthma
The exposome comprises a person's entire environmental exposures
that a person experiences, from conception throughout its life
course. The concept was introduced in 2005 as the environmental
counterpart of the genome to underscore the importance of the
total environment to human health and to bring research efforts in
line with those on the human genome.1 This definition was
expanded later by incorporating behavioral risk factors, the body's
response to environmental influences (resilience or allostatic load),
and the endogenous metabolic processes that modulate exposure.2,3
Wild differentiated between the “eco‐exposome” as the point of
contact between an external environmental stressor, the biological
receptor of an individual, and the “endo‐exposome” as the inward
effects arising from exposure on those receptors.3 Vriejheid
described a general external environment (climate, urban environ-
ment, green spaces, traffic, and social capital), a specific internal
environment (smoking, diet, physical activity, water, and consumed
products), and an internal environment measured through ‐omic (e.g,
genomic, transcriptomic, and proteomic) tools.4
The exposome and biology are highly interactive: Changes in
biology due to the environment modulate vulnerability to subse-
quent exposures. The balance between the biological effects of
exposure (binding to macromolecules, structural changes, enzyme
function disruption, damage through reactive oxygen or nitrogen
species) and the specific biological responses (ubiquitination, autop-
hagy, proteolysis, DNA repair, antioxidant systems, and so on) repre-
sents the biological impact of the exposure. The level of resilience is
key for maintaining health and the cumulative cost of the correction
process (allostatic load), and it is an important footprint of the
exposome. Linking exposure to the specific biological responses in
exposome research could improve understanding of the mechanistic
connections between exposures and health to help mitigate adverse
health outcomes across the life span. Moreover, the exposomic
approach is particularly applicable to study chronic diseases such as
allergic diseases and asthma since it provides a risk profile instead of
single predictors.
2.2 | The exposome versus genome, transcriptome,
proteome, epigenome, and metabolome in driving the
disease phenotype and endotype
Each of the exposome domains induces a multitude of –omic
responses. As an example, air pollution exposure interacts with the
genome to perturb biological events in asthma pathways.5 Novel
insights into how these responses occur following individual and
combined exposures, and their associated health impacts, continue
to emerge. Genetic polymorphisms also interact with many other
environmental stressors to generate asthma phenotypes such as
decreased lung function, adult‐onset asthma, or the severe asthma
phenotype.5-9 Air pollution also induces transcriptomic, epigenomic,
and metabolomic responses.10-12
A few recent studies interrogated the transcriptomic effects (i.e,
whether genes are turned on and off) of environmental exposures.
Searching for genes differentially expressed under different expo-
sures over multiple experiments is the basis for the transcriptome‐
wide association studies (TWAS). In another recent study, ex vivo
peripheral blood mononuclear cell transcriptomic responses from
asthmatic children to rhinovirus infection provided a personalized
framework for predicting asthma exacerbations with 74% accuracy.13
Proteomic studies are emerging as well. A proteomic signal in breast-
milk featuring protease inhibitors and apolipoproteins distinguished
between allergic and nonallergic mothers.14 Nasal protein profiles
from brush samples were compared between healthy adults and
adults with asthma occupationally to protein allergens, isocyanates,
or welding fumes. Hierarchical clustering revealed greater differences
in asthma related to welding fumes when compared to protein aller-
gen and isocyanate‐related asthma.15 Proteomic analysis of bron-
choalveolar lavage fluid in patients with asthma revealed that
approximately 150 distinct proteins were significantly upregulated
after exposure to allergens. These proteins were linked to inflamma-
tion, eosinophilia, airway remodeling, tissue damage and repair,
mucus production, and plasma infiltration.16
The exposome represented by presumed seasonal exposures was
related to epigenetic associations, adult blood DNA methylation that
was enriched for genes important to development, the cell cycle, and
apoptosis. DNA methylation in a smaller subset of CpG sites was
nominally associated with adult allergic outcomes.17 Environmental
exposures have also been shown to combine with genetic and epige-
netic components to influence asthma outcomes: Particulate matter
2.5 μm (PM2.5) exposure over 7 days, one common DNA sequence
variation, and CpG methylation levels jointly affected airway inflam-
mation (i.e, FeNO levels) in the Children's Health Study cohort.18
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The importance of the infant microbiome and its associated
metabolome on the risk of developing allergic diseases is gaining
greater recognition.19,20 Exposure of healthy volunteers to air pollu-
tion for 5 h induced metabolic features in the blood, some of which
were associated with reductions in lung function.21
In summary, while the discovery of ‐omic patterns has great poten-
tial to inform on the impact of the exposome on asthma endotypes
and phenotypes, this field is relatively young and with an unclear
future impact in the field of respiratory care. Ongoing initiatives, such
as the Human Early‐Life Exposome (HELIX) project of six existing
European birth cohort studies, will compare prenatal and postnatal
chemical and physical exposures to transcriptomic, proteomic, epige-
nomic, and metabolomic molecular profiles.4 Future studies may con-
sider improving the interacting ‐omic measures, such as the
“Interactome,” which uses a more multi‐axial systems approach to
identify the relevant networks that underlie asthma and allergic dis-
ease.22 Combined genomic, transcriptomic, epigenomic, and metabolo-
mic analyses of the regulation of asthma control generated lipidomic
data that were integrated with a conditional Gaussian Bayesian net-
work using the strongest predictors (mRNA, CpG sites, and SNPs)
identified. Remarkably, four single nucleotide polymorphisms (SNPs)
and two metabolites strongly predicted asthma control.23
2.3 | Development of the exposome through
biomarkers
The ability to characterize environmental exposures through biomoni-
toring is key to exposome research efforts. To understand the complex-
ity of exposures faced throughout the life span, both traditional and
nontraditional biomonitoring methods should be used.24,25 Exposomic
approaches differ from traditional biomonitoring methods in that they
can include all exposures of potential health significance, whether from
endogenous or exogenous sources. Issues of sample availability and
quality, identification of unknown analytes, the capture of nonpersistent
chemicals, integration of methods, and statistical assessment of increas-
ingly complex data sets remain challenges that must continue to be
addressed. Exposome‐Explorer (http://exposome-explorer.iarc.fr) is the
first database dedicated to biomarkers of exposure to environmental
risk factors with detailed information on the nature of biomarkers, their
concentrations in various human biospecimens, the study population
and the analytical techniques used for measurement, correlations with
external exposure measurements, and data on biological reproducibility
over time.26 The Exposome‐Explorer makes it easy to compare the per-
formance between biomarkers and their fields of application and is par-
ticularly useful for epidemiologists and clinicians wishing to select
panels of biomarkers that can be used in biomonitoring studies or in
exposome‐wide association studies (EWAS).
One of the main aims in prevention is to predict individual risk
related to the early environment to potentially allow for intervention
prior to disease onset. Biomonitoring during critical time windows of
susceptibility (Figure 1) and during different phases of disease from
inception to chronicity 27 also has the potential to validate new tools
for risk assessment and to estimate the burden of environmental
disease. Exposomics and Helix are two large consortia funded by the
European Commission focusing on: (a) “reduction of uncertainty”
paradigm; (b) the role of multiple environmental contaminants in dis-
ease risk, on the basis of improved exposure assessment; (c) novel
chemical risks identified via untargeted ‐omics (“hazard identifica-
tion”); and (d) the burden of disease attributable to environmental
agents (how the latter changes with improved exposure assessment
and risk estimation for selected exposures and diseases). HELIX has
a special focus on children. Combined, they are expected to reach a
refined model for exposure risk assessment that would have an
impact on environmental policies.
As shown in Table 1, numerous biomarkers of environmental
exposures have been identified that may quantify or predict the indi-
vidual risk of disease. These biomarkers can be classified as biomark-
ers of exposure, intermediate biomarkers of early effect (biomarkers
of susceptibility), or biomarkers of response/disease (Figure 2). Fur-
thermore, biomarkers of exposure relevant to allergic diseases and
asthma can be grouped according to the stressor (Figure 3).
Biomarkers may be combined with predictive models for individ-
ual exposure and questionnaire data to obtain greater accuracy in
environmental exposures. For example, cotinine biomarkers validate
questionnaire responses on environmental tobacco smoke, and
indoor air pollution biomarkers (e.g, PAH‐DNA adducts) validate
questions on cooking and heating sources in the home.
2.4 | The complex network—the building
environment, allergens, infections, occupational
exposure, and school environment
Both increased urbanization and the increased amount of time spent
indoors (residences, workplaces, public buildings, etc.) to almost
F IGURE 1 Several types of exposure occurring through lifetime
are relevant for the impact of the environment for allergic diseases
and asthma. 1. Early life exposure. Environmental stressors in early
life are major contributors to allergic diseases and asthma. 2. Linear
incremental exposure (eg ageing effect) 3. Occupational exposure 4.
Chronic low level exposure 5. Multiple‐hit exposure: a combination
of intermittent and persistent exposure with variable dose and
length of exposure (weight gain/loss, diet, exercise, pollution,
microbiome, habitat change, etc)
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80%‐90% point to the need to characterize the built environment
exposome and the factors that shape it.28 Within the built environ-
ment, exposure to external physical factors, chemicals, or biological
agents, including indoor allergens, pathogens, insects, and their asso-
ciated biochemicals, impacts the risk of developing allergic diseases
and asthma, and hampers the control of the disease. Highly diverse
and complex microbial communities, known as microbiomes, inhabit
all areas of the built environment, including food, tap water, indoor
air, and various surfaces. These microbial constituents are continually
being ingested, inhaled, and colonized the skin and mucous mem-
branes. The physical, chemical, and microbial components of the
exposome are highly interrelated. For example, inhalation of house
dust is accompanied by exposure to microorganisms and allergens.
Free chlorine, a strong oxidizing chemical routinely added to water
systems to kill pathogens and limit microbial growth, also produces a
range of unwanted disinfection by‐products which might alter the
integrity of epithelial barriers. Thus, a holistic and comprehensive
understanding of the exposome in the built environment is needed
to design a framework for informing design and control of buildings
in a manner that promotes human health and well‐being.
Net effects of the environment on the development of allergic
diseases and asthma are likely to depend on the sum of (or interac-
tion between) numerous exposures. For example, the traditional
farming environment is associated with lower rates of childhood
allergic diseases and asthma.29 Studies in western Europe indicate
that there are several specific exposures that may mediate these
beneficial effects, including consumption of raw farm milk, contact
with animals, a rich microbial environment, and contact with grains
and silage.30 In urban environments with high rates of poverty, envi-
ronmental exposures and effects on allergy and asthma are quite
complex. On the one hand, increased exposure to microbes and high
levels of certain allergens (cockroaches, mice, and cats) are inversely
associated with allergic sensitization, wheezing, and asthma. These
observations are similar to the effects of some farm exposures.31,32
On the other hand, exposure to high rates of stress, tobacco smoke,
and outdoor pollutants, prenatally or in early life, promotes allergies
and/or asthma. The hygiene hypothesis was initially proposed as an
explanation for the alarming rise in allergy prevalence in the last cen-
tury stipulating that the lack of infections associated with a Western
lifestyle leads to a reduction in type 1 immune responses. During
the last few years, tolerance to allergens has become central in the
hygiene hypothesis in the last years. Loss of adequate microbial
stimulation due to a Western lifestyle and immunostimulatory envi-
ronmental signals during early life or passed on by the mother
are key elements supporting the observed rise in type 2 allergic
diseases.33
Allergic sensitization can also modify the effects of respiratory
virus infections. For example, children who are highly sensitized
to allergens are at increased risk of rhinovirus wheezing ill-
nesses.34 Notably, treatment with omalizumab led to several benefi-
cial effects including increased virus‐induced interferon responses
and reducing the frequency of viral detection and viral illnesses.35,36
Pollutants such as NO2 also increase the risk of virus‐induced
wheezing in children.37
The effects of respiratory virus infections also depend on host
genetics. In addition to the aforementioned examples with air pollu-
tion, polymorphisms in the 17q21 region are associated with higher
risks of wheezing with rhinoviruses and also greatly increase the risk
of developing asthma, following a rhinovirus wheezing episode.38
Interestingly, in children with these same variants, farm exposures
decrease the risk of subsequent asthma. The same genotype can
confer genetic risk and also allows for protection in the farm envi-
ronment.39 In addition, children with polymorphisms in cadherin‐
related family member 3 (CDHR3), the receptor for rhinovirus C, are
more likely to develop rhinovirus C infections and illnesses, and ulti-
mately childhood asthma.40-42
The occupational environment is an important source of health
hazards, including lung diseases.43 With the continuous introduction
F IGURE 2 Development of the
exposure through biomarkers
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of new agents and technologies in the workplace, new occupational
threats and diseases are being described,44 some of which can be
particularly difficult to ascertain.45 The occupational exposome
describes the entire workplace exposures that interact with the gen-
ome and other environmental factors that may provide important
clues for the understanding of chronic work‐related diseases. The
identification of new hazardous agents and the validation of environ-
mental and biological indicators of exposure and effect are important
goals in surveillance of work‐related diseases and in prevention of
new health hazards. Faisandier et al., have proposed a theoretical
framework of the occupational exposome using a network‐based
approach for characterizing occupational health problems linked by
similar workplace exposures.46 This model can allow the assessment
and characterization of relevant disease‐exposure associations in the
form of a relational network. The occupational exposome can be
analyzed at the level of an isolated disease or at the level of several
diseases, considering different dimensions of the workplace expo-
sure, such as job title, hazards, activity, and so on.46 The characteri-
zation and a better understanding of the occupational exposome can
be of great value to unveil the pathogenic mechanisms of chemical‐
induced adverse effects and should open the way to implementation
of effective preventive strategies.47
Children spend 6‐10 h per day in school, which is a substantial
proportion of their time away from home. The school/daycare envi-
ronment may therefore be viewed as a child's required occupation.
The school environment represents a distinct set of exposures.
Schools are also typically centrally located within a community and
may be in closer proximity to heavy traffic routes and industrial
exposures than residential areas.48,49 The school is also a hub for
pick‐up, drop‐off, and idling cars and buses, potentially contributing
to a site‐specific increase in ambient pollution. These factors make
schools a unique microenvironment of indoor exposures and an area
of investigation relating school and home exposures to allergens,
molds, pollutants, and other microbial exposures.50-55
The implementation of public smoking bans and clean air policies
has led to a reduction in the hospitalization for asthma, and these
policies should be reinforced in as many countries as possible.56
School‐specific targeted intervention work is ongoing.51,57
2.5 | Diet, lifestyle, social and psychological factors,
city planning, and social determinants of health
Diet is becoming increasingly recognized as an external exposure
relevant to allergy and asthma, although the specific risk determi-
nants are not well understood. However, in one large study from
the NutriNet‐Santé cohort, the association between the overall
quality of diet evaluated by three dietary scores and the asthma
symptom score and control was investigated in 34 766 participants.
Roughly 25% of participants reported at least one asthma symp-
tom. A negative association between a healthier diet and the
asthma symptom score indicative of poorly controlled asthma was
observed in men (odds ratio [OR] 0.39) and, with borderline signifi-
cance, in women (OR 0.73). Healthier diet behaviors were
associated with fewer asthma symptoms and better asthma con-
trol.58 In the pooled analysis of the Dutch Maastricht Essential
Fatty Acid Birth and the Greek RHEA Mother‐Child cohorts, higher
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) con-
centrations and a higher n‐3:n‐6 fatty acid ratio at birth were asso-
ciated with lower risk of childhood wheeze and asthma. Dietary
interventions resulting in a marked increase in the n‐3:n‐6 polyun-
saturated fatty acid (PUFA) ratio, and mainly in n‐3 long‐chain
PUFA intake in late gestation, may reduce the risk of asthma
symptoms in mid‐childhood.59
Other dietary exposures have been linked to allergy and asthma
through their induction of relevant biomarkers or pathways (Table 1).
For example, a single McDonald's meal promotes oxidative stress
and increases the expression of inflammatory genes.60 Advanced gly-
cation end products (AGEs) are highly oxidant compounds formed
through the nonenzymatic reaction between reducing sugars and
free amino acids, and they are found at high levels in fast foods.61
Thus, a single meal high in AGE can boost oxidative stress and vari-
ous markers of metabolism.62 Furthermore, the effects of such meals
on allostatic load may be more pronounced in those who are physi-
cally inactive. On the other hand, a single healthy meal incorporated
into standard Westernized dietary practices each day (e.g,, lunch
based on traditional Mediterranean or Japanese diet) can reduce
markers of allostatic loads.63,64
However, many questions remain to be solved concerning the
extent to which the allostatic load can be modulated by the back-
ground diet in the context of concomitant intervention of stress, the
immune system, microbiota, socioeconomic status (SES), and numer-
ous other factors.65 Several studies have shown that antioxidant tis-
sue levels of antioxidants that would buffer the effects of the
allostatic load are lower in persons with individual and neighborhood
SES disadvantage.66,67 Neighborhood disadvantage is associated with
lower microbial diversity as well.68 The diet can undoubtedly influ-
ence the microbial ecosystem, and at the same time, the biophysiolo-
gical response to the diet will be influenced by the gastrointestinal
microbial ecosystem.69 Levels of blood antioxidants and omega‐3
fatty acids may also be a product of the intestinal microbial diversity
dependent upon the consumption of essential fats and deeply col-
ored, fiber‐rich plant foods.70,71
The exposome also encompasses a wider set of psychological,
social, and behavioral variables that include stress, subjective well‐
being, personality traits, resilience, social connectedness, and social
support. Constructs such as stress and social isolation may seem
hard to pin down, but there are well‐validated instruments for mea-
suring them from social science and psychology. The ability to mea-
sure these constructs electronically—via smartphones (e.g, Ecological
Momentary Assessment), social media (e.g, tweets reflecting mood),
and electronic health records opens the door for their widespread
inclusion in exposome research.
Many factors that influence our health operate at the societal
rather than individual level: cultural background, SES, access to
health care, and high‐quality education, coined by Jacquez and Sabel
as “behavome”.72 Geo‐coding via geographic information system
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(GIS), as discussed later, can capture some of these societal factors,
opening up additional possibilities of linking neighborhoods and com-
munities to disease outcomes.
Urban green spaces are a key element in the planning of today's
cities because they favor the interaction between citizens and the
environment, as well as promoting human health. Urban landscape
elements, particularly trees, have the potential to affect airflow, air
quality, and the production of aeroallergens. Improved air quality
and respiratory health are among the anticipated economic and
social benefits of the urban forest. More vegetation within a 100‐m
or 250‐m buffer around the home was associated with lower per-
sonal exposure to particulate matter ≤2.5 μm (PM2.5).73
Lack of planning in the design of urban spaces with low species bio-
diversity at planting, overabundance of species acting as pollen sources,
exotic species prompting new allergies in the population, botanical sex-
ism, the presence of invasive species, inappropriate garden management
and maintenance activities, cross‐reactivity between phylogenetically
related species and the interaction between pollen, its microbiome, and
air pollutants are major causes triggering pollen allergy.74-76 In recent
decades, city planning strategies have favored pollen‐producing male
bushes, trees, and plants. These “litter‐free” male plants are chosen to
avoid having to clean up the seeds and fruit produced by pollen‐collect-
ing female plants. This practice known as botanical sexism drives up pol-
len counts in urban areas, which subsequently affects allergy symptoms.
Given that many modern cities currently fall below the ideal tree canopy
level (40% of the city area), there is an opportunity to plant more female
trees and shrubs, while also considering the overall allergy potential of
particular species. Insect pests infesting landscape trees and shrubs pro-
duce insect dander and sticky secretions (“honeydew”) that trap air-
borne mold. The result is a tree or shrub that is highly allergenic.
Songbirds are the best defense against these pests, and thus, planting
fruiting plants specifically to attract and feed the wild native songbirds
is recommended. A long‐range plan for eradication of dominant weeds
is also helpful. Regulations on keeping grass lawns mowed in order to
avoid getting too tall and releasing allergenic pollen should also be
enforced as a public health issue. In addition, a thick, healthy, regularly
mowed lawn makes an excellent trap for pollen that comes from nearby
trees or shrubs. Female clones of grasses such as buffalograss should be
encouraged since they use very little water, require less fertilization,
and they produce no pollen. There is a clear need for guidelines regard-
ing the design and planning of urban green spaces with a low allergy
impact. Active consultation with botanists and allergists for city planning
should be advocated.
3 | THE EXPOSOMICS
Currently, there is no standard or systematic way to measure the
influence of environmental exposures on health. Documenting expo-
sure is highly challenging: Different classes of offending agents
(physical, chemical, biological, and psychosocial) from various sources
(water, air, soil, food, consumer products, and medicines) encoun-
tered in various places (home, school, work, neighborhood,
community, travel, etc.) or in different life stages (fetal, child, adoles-
cent, adult, and elderly) engage contact with our body through dif-
ferent entry gates (lung, skin, and gut) and target different biological
pathways in different organs. Documenting exposure is relatively
easy for high‐dose chronic exposure. However, for low dose chronic
exposure proper documentation is hampered by the sensitivity of
the assay, for intermittent exposure by the frequency of testing
while for transient exposure the system should be in place at the
time of exposure or the evaluation relies on the measurement of the
footprint (the biologic response or allostasis).
There are two current approaches in the exposomic research:
the bottom‐up (targeted) approach building from known exposures
and connections to the molecular initiating event generating the dis-
ease; and the top‐down (untargeted) approach starting in an unbi-
ased fashion from the disease and the initial molecular event aiming
to discover novel exposures and connections.77,78 The targeted
approach relies on biomonitoring levels of known analytes (chemical,
biological) in a sample, environmental monitoring, and questionnaires.
The untargeted approach relies on ‐omic tools searching for patterns
and peaks followed by validation. The semi‐targeted (hybrid)
approach uses computational biology to expand the list of targets
and then develops biomonitoring methods.
While exposure to outdoor air pollution, pollen, temperature,
noise, water and soil contaminants, ultraviolet radiation, and green
space is generally measured and/or modeled on a population level,
exposure to food contaminants, consumed products, indoor pollu-
tants and aeroallergens, and physical activity is evaluated at an indi-
vidual level. Individual assessment may be used to build or validate
environmental models. Environmental exposure and dose estimates
can be linked with ‐omic data to obtain biomarkers of exposure or
diseases and to determine mechanistic pathways underlying the
environmental endotypes.
The ideal exposure measurement evaluates multiple sample types
(biological, questionnaires, etc.) across relevant matrices using vari-
ous analytical methods and integrates ‐omic tools in a dose and
time‐to‐response studies using experimental model systems to gain
detailed mechanistic information.
The evaluation of the exposure needs to follow the same
approach used to assess genetic relationships in the genome‐wide
association studies (GWAS). The GWAS approach controls for multi-
plicity; it is comprehensive, transparent, and unbiased and allows val-
idation of novel findings. The linkage with disease risks opens the
way to EWAS. By taking a data‐driven, agnostic, unbiased approach,
EWAS leads to more reproducible hypotheses.79 The goal of EWAS
is to sort through the thousands of environmental stressors to which
people are exposed during life and identify those few exposures that
may be the causes of disease. Epidemiologists can then follow up
with focused studies to establish causality. Research into the rela-
tionships between external exposures and global profiles of molecu-
lar features (as measured by ‐omics) constitutes a novel advance
toward the development of “next‐generation exposure assessment.”
Genes are turned on and off as the function of exposure. If cau-
sal, exposure must influence biology via gene expression.80 Searching
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for genes differentially expressed under different exposures over
multiple experiments is the basis for the TWAS.
3.1 | Standardized measurement platforms and
measurement harmonization
Exposomics relies on sensors and big data. However, more data are
not equivalent to better information: We need the right data and
furthermore to determine their relevance. Many challenges need to
be overcome: selection of relevant sensor data sources, modeling a
high temporal‐spatial grid, characterizing uncertainty, and data inte-
gration to support ease of use. The four “V”s of measurement plat-
forms that exposomic research needs to find a solution for are
Variety (no standards—heterogeneous), Velocity (multiple data gath-
ered per second), Volume (data accumulated over long times and
from multiple sources), and Veracity (significant uncertainty, variabil-
ity, and gaps—noisy data).
Exposomic research lacks a comprehensive environmental health
surveillance system. Barriers to build this system include available
resources, communication strategies, data comparability and sharing,
and political will. Anticipated benefits include high‐quality data,
informing public health, environmental decisions and benchmarking
the success of public health interventions, improved risk assessments
for environmental stressors, and new ways to prioritize environmen-
tal health research.
3.2 | Informatics and data analytics to support
exposome‐based approach for allergic diseases and
asthma
Whereas genomic data consist of stable linear sequences, exposome
data are heterogeneous, nonlinear variables that change over time
and space. Dense webs of correlation among environmental variables
make it hard to tease out causation. Exposome researchers can rely
on the bioinformatics tools developed for GWAS, but to fully
develop the exposomic approach, exposure to new tools for storing,
integrating, and analyzing the data is needed.
Exposure assessment in exposome studies involves large
amounts of data collected at multiple scales and life stages. Major
challenges include how to integrate and interpret data in a meaning-
ful way, how to account for shared exposures, how to integrate data
across multiple spatial and temporal scales and methodological
approaches, and how to adjust for measurement errors.
The aggregate exposure pathway (AEP) framework, a concep-
tual framework that complements the adverse outcome pathway
(AOP) concept, organizes exposure and data from source to dose
and to outcome.81,82 In the dynamic adverse outcome pathway
model proposed for systems toxicology, quantitative system‐wide
molecular changes in the context of an exposure are measured,
and a causal chain of molecular events linking exposures with
quantifiable outcomes in the target organs (histology, imaging, and
functional tests) is proposed. Mathematical models are then built
to describe these processes in a quantitative manner. The
integrated data analysis leads to the identification of how biologi-
cal networks are perturbed by the exposure and enables the
development of predictive mathematical models of toxicological
processes. Together, the two frameworks complete the view of
the exposure‐outcome continuum to enable knowledge integration
and a better understanding of the health impacts of exposure. In
addition, the AEP framework supports exposure modeling and
forecasting by organizing exposure data within individual units of
prediction.
Few studies have attempted to comprehensively quantify cor-
relations among multiple exposures. In an analysis of 81 environ-
mental exposures assessed during pregnancy via a range of
biomonitoring, geospatial modeling, remote sensing, and question-
naire approaches, Robinson et al reported a weak correlation
among exposures overall but a stronger correlation among expo-
sures within the same family, suggesting that adjustment for
potential confounding between families of exposure may be per-
mitted in future epidemiological studies of the exposome.83 The
authors also note that correlations may be inflated for exposures
assessed using a similar methodological approach, for example, the
same analytical platform or modeling input variables, possibly
obscuring true exposure variability. Considering the interdependen-
cies of the exposome, Patel and Manrai constructed an “exposure
correlation globe” to identify and display correlated clusters of
exposures by extending unsupervised learning approaches originally
developed for use with genomic data to 81 937 environmental
exposures collected as part of four consecutive NHANESs.84 The
correlation globe provides a complex view of exposure: Looking
for the hubs of the network, one can deduct what factors are
correlated with others the most. The results of these and related
models will provide a better understanding of the estimated effect
and on how to appropriately identify and adjust for potential
confounding.
Statistical methods need to solve problems from technology‐
related biases (errors occurring across scales of measurement with
different precision and analyte, use of multiple measurement tools
with different sampling strategies), bidirectionality, reciprocal rela-
tionships, intraindividual variability, idiographic effects, and feedback
loops. Additional research focused on capturing time‐varying effects
is also required.
There are both opportunities and challenges in creating a search
engine supporting the exposomic approach. High‐throughput meth-
ods are systematic, are reproducible, and allow control for multiple
hypotheses, and the results support scientific prioritization. The
challenge derives from the big data yielded by the high‐throughput
methods since there is the risk of big bias and it is not easy to dis-
entangle the dense correlational web. The researcher might end
with fragmented and small associations. Other challenges are con-
founding factors, reverse causality, and the influence of time and
life course.
In addition, there is a need for expansion of the data resources
to increase the analytic power to query the biological role of EWAS
discoveries.
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3.3 | Precision medicine and big data approach
The precision medicine approach relies in part on the integration of
patient‐centric molecular, environmental, and clinical “big” data into
targeted management pathways.
Few methods exist to ensure that big data resources motivated
by precision medicine are being used reproducibly. Relevant chal-
lenges include integrative analyses of heterogeneous measurement
platforms (genomic, clinical, quantified self, and exposure data), the
trade‐off in making personalized decisions using more targeted but
potentially much noisier subsets of data, and the unprecedented
scale of asynchronous observational and population‐level inquiry (i.e,
many investigators separately mining shared/publicly available data).
Another challenge for the implementation of precision medicine
involves novel methods for assessing data quality. Software that
enables analysts to transparently document analysis protocols can
help ensure reproducibility.85-87
The Biomedical Data Translator (BDT) program, sponsored by
the National Center for Advancing Translational Sciences (NCATS) of
the National Institutes of Health, is exploring novel approaches to
interrogate big data for precision medicine applications in ways that
can be very powerful in assessing the impact of the exposome on
human health. This project involves 13 teams of data scientists,
specific content experts, physicians, and other scientists from
NCATS and 17 universities and research centers working in a coordi-
nated fashion to develop a data integration and translation tool. This
project focuses on developing application programming interfaces
that can interrogate a number of disparate knowledge sources that
describe and/or impact human biology.
At present, 40 distinct knowledge sources have been included
in this project, which includes data on environmental exposures
available from the US Environmental Protection Agency, data on
socioeconomic data (income level, access to health insurance, and
transportation) available from the US Census, electronic health
record data, accessed with appropriate regulatory oversight (clinical
measures, diagnostic assessments and tests, diagnoses, interven-
tions, and drug exposures), and data from a number of open data
sources. These open source data include exome or genome pedi-
grees, experimental and mechanistic data on molecular biology and
biological pathways, systems biology, and chemical structures and
drug targets.
As the BDT data protocols and procedures evolve, there will
be a number of ways to expand access to environmental and
other novel data sets with those outlined above to allow for
queries focused on the impact of exposome elements on allergic
and immunological diseases. For example, there are emerging data
that demonstrate that exposure to ambient air pollutants modifies
the gut microbiome.88,89 While the microbiome is beyond the
scope of this review (and the focus of the previous PRACTALL), it
is noteworthy that there are emerging data to suggest that ambi-
ent environmental particulate matter impacts airway and gut
microbiome, as well as microbiome influences on pollen biology.
Additionally, there are data that indicate that biodiversity
(including microbial diversity) is associated with improved human
health and that indoor biomass pollution impacts human micro-
biome.90 As microbiome data sets become available to BDT‐type
approaches, there will be richer approaches to assess exposome
effects on human health.
4 | EXPOSOME VISION AND CHALLENGES
In addition to the application of biomarkers and of integrated big
data approaches for multi‐analyte exposure assessment, the transla-
tion from exposure biology to exposomics needs integration of tem-
poral‐spatial variation in the exposome, including over the life
course. This includes tools for measuring the individual external
exposome over the life course and research that translates expo-
some data to improved public health policy.
4.1 | Addressing the dynamic, life course nature of
the exposome
The impacts of environmental exposures on health effects over the
life course are dynamic (Figure 1). Emerging data have identified sev-
eral key time windows of susceptibility on asthma and allergic out-
comes. One is the prenatal time period, as Hsu et al., demonstrated
using satellite‐based spatiotemporal measures to model daily PM2.5
exposures throughout pregnancy on physician diagnosis of asthma
by age 6 years, mid‐pregnancy at 16‐25 weeks’ gestation, especially
for boys.91 When PM2.5 measures are combined with maternal stress
exposure, the prenatal time window of susceptibility may narrow to
19‐23 weeks.92 When NO3− measures are combined with high
maternal stress, pregnancy remains a key period.93
Lagged exposure‐response associations have also been
observed. For example, 7‐day lag periods with 10 μg/m3 increase
in PM and hospitalizations for asthma were detected in Seoul, S.
Korea, especially among elderly participants.94 Differential effects
related to the sequence of exposures and the timing of exposures
were elegantly demonstrated in experiments by Clifford et al.
Here, initial priming effects on DNA methylation in bronchial
brushings of airway epithelial cells of experimentally exposed die-
sel observed at 48 h were amplified 4 weeks later following a sec-
ond exposure with the allergen. Interestingly, when the sequences
were reversed, a different pattern of CpG methylation became
evident.95
Addressing the dynamic, life course nature of the exposome can
be done using birth cohorts specifically addressing the exposome
with prospective follow‐up or extend across multiple generations or
by longitudinal studies with repeat measures of multiple exposures
(e.g, Helix, ECHO). Integrating data from several cohorts that
together mimic all life stages is evaluated by EXPOSOMICS by pool-
ing together data collected from birth cohorts (RHEA and PIC-
COLI+), childhood cohorts (INMA and ALSPAC), adolescence
(PISCINA), early adulthood (SAPALDIA and EPIC‐SCAPE), adulthood
(OXFORD‐ST), and mid‐ and late life (MCC and EPICURO).
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4.2 | Tools for measuring personal environmental
exposures
Major scientific and technological advances currently support the
assessment of the exposure: geographic information system (GIS);
remote sensing; global positioning system (GPS) and geolocation
technologies; portable and personal sensing, including smartphone‐
based sensors and assessments; and self‐reported questionnaire
assessments, which increasingly rely on Internet‐based platforms.
Many instruments are currently available to measure personal
exposure to specific exposome domains. These can be divided into
personal or wearable monitors, and stationary monitors that record
fixed measurements from the location where they are placed. For
example, small, mobile monitors that capture air pollutants are
becoming increasingly available, even commercially. While the sensor
technologies may differ across instruments, personal monitors advan-
tageously capture spatiotemporal trends with high resolution and
reliable validity, especially for fine particles, gasses such as O3, NO2,
CO, and volatile organic compounds.96,97 They also permit assess-
ments of the relationships between the intensity of environmental
exposures that may change with individual activities or inhalation
rates, such as those related to sleep, exercise or type of exercise,
and commuting to work or school,98 and can be filtered into real‐
time computer navigation systems for further coverage.99
Accelerometers count steps and sleep times; heart rate monitors
may gauge exercise intensity.
New smartphone‐linked diaries and imaging provide additional
tools for capturing the exposome. In addition to facilitating the cap-
ture of how air pollution exposure changes with individual activities
and by GPS‐derived location, they may help ascertain diet and use
of consumer products. Smartphone cameras snap photographs of
food to provide a more accurate account of dietary intake. All these
data can then be overlaid with GPS data to learn about context,
such as which locations are most conducive to exercise. Using GPS‐
enabled smartphones, spatial‐temporal paths (also called “space‐time
cubes”) can be intersected with spatial‐temporal maps of environ-
mental hazards (e.g, the hazard map) or even the density of fast food
restaurants to quantify individual exposures.
Residential air monitors, placed on one's school, office, or even
moved from location to location at certain intervals, may capture
indoor exposures missed by general methods such as GIS. Residential
monitors also readily capture outdoor pollutants that penetrate inside
related to high air exchange rates, such as black carbon/soot and trace
elements. Particular attention needs to be paid toward features of the
location, such as whether the sensor faces a street, alley, or green
space, as well as floor height.99,100 For both personal and residential
monitors, consideration of quality assurances and controls and pro-
cessing of the data is important. Other considerations may relate to
the effects of season, limits of battery power, reproducibility, and nor-
malization of background noise.97 Moreover, residential dust can be a
reservoir for allergens and microbial products that are relevant to the
onset of allergic diseases and their prevention.101
F IGURE 3 Biomarkers of exposure can
be classified according to the
environmental stressor. The best
exposomics biomarker is related as many
exposures as possible
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GIS has transformed environmental health research by integrat-
ing databases that connect different attribute data by geographic
location. Data on external environmental exposures obtained from
remote sensing, geolocation technologies, or sophisticated modeling
outputs can be combined with health attribute data obtained via
personal sensing or other approaches. GIS integrates topologic
geometry, which can manipulate geographic information, with auto-
mated cartography, enabling users to compile digital or hard‐copy
maps. GIS can quantify buffer distance between an exposure source
and a human receptor and may be used to characterize proximity to
roadways, factories, and green spaces. GIS can also display and
analyze mobility of people as they travel through the external
environment.
Remote sensing technologies are useful for external exposure
assessment in areas where ground‐based monitoring is not available.
There is an expanding list of environmental exposures that can be
measured via remote sensing such as PM2.5 and NO2 concentrations,
green spaces, temperature, and the built environment.102 A major
advantage of remote sensing is that it has virtual global coverage,
useful for large population studies.
Future challenges in portable and personal sensing include mea-
suring longer‐term exposures and health outcomes, reducing cost,
improving operability for application in larger population‐based stud-
ies—in particular to avoid problems in compliance, potential sampling
bias, and behavioral change due to wearing of the monitors—
improving reliability and quality of data, measuring a greater number
of exposures, and integrating and interpreting data from diverse
sources. Unfortunately, most personal environmental sensors remain
too bulky and costly to deploy on the thousands of participants
needed for EWAS‐type studies. Further research to validate the
expanding number of available software applications and improve
personal devices with additional features such as more miniaturiza-
tion is also required. Although assessment of the exposome is based
largely on objective assessments due to economic reasons,
population‐based studies will still rely on questionnaires and surveys
as inexpensive and effective ways to capture self‐reported, personal
characteristics and historic exposures from a large population. Infor-
mation from questionnaires on residential and occupational history
can still be linked to the growing number of geospatial data sources
to create integrated metrics of exposure to environmental contami-
nants, such as air pollution. Technological improvements regarding
how questionnaires are administered (e.g, smartphones, social media,
and social networks) allow quick integration of reported data into
the analytical data sets.
4.3 | The relevance of the exposome data to
clinical practice and to policy advocates
Bit by bit, progress in describing human exposure is made. However,
several gaps need innovative solutions such as integrating all the lay-
ers of exposomic data and linking them to genome data to estimate
the gene‐environment interactions. The exposome community needs
to adopt the “big science” approach similar to the Human Genome
Project by investing in improving measurement technologies,
establishing a data repository for exposures that allow data sharing
and agree on standards, such as for variable names, meta‐data,
and security.
Exposomic research must also evaluate the practical considera-
tions related to operational parameters, training, and funding, includ-
ing balancing costs versus the necessary accuracy for technological
deployment in large‐scale studies. Adequate training to current and
future researchers and research users is urgently needed to facilitate
transdisciplinary collaborations on both targeted and broad‐spectrum
external exposure applications.
The new 2012‐2017 Strategic Plan for the National Institute of
Environmental Health Sciences (NIEHS) combines fundamental and
exposure research with detailed focus on health disparities and glo-
bal environmental health. Training and education, communication,
F IGURE 4 The holistic approach of the
exposome to the environmental causes of
allergic diseases and asthma leads to better
understanding of disease mechanisms
driving the environmental endotypes and
phenotypes and supports the development
of management pathways for prevention
and disease control in clinical practice and
the advocacy effort to improve public
health
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and implementation as a support for the implementation science are
further prioritized.
There are also funding implications, such as the need for larger
exposome‐related research grants and transdisciplinary research cen-
ters, though this challenge does not preclude the use or leveraging of
existing resources, including incentives for multisector (public and pri-
vate sectors) initiatives to integrate the exposome into ongoing work.
The ideal exposome should fulfill the following criteria:
• Measures a wide spectrum of exposures
• Quantifies relevant biological exposure at the target site
• Not influenced by simultaneous measurement of other exposures
• Stable
• Sensitive to changes over time
• Provides a measure of both recent and remote exposure
For the utility of the exposomic approach for allergic diseases
and asthma, there are still several open questions
• What is the population of interest (“the model”)?
• What is the nature (duration, frequency, timing) and magnitude
(concentration and dose) of relevant exposures?
• Which associations are relevant for a particular allergic disease?
• What are the mechanisms driving the environmental endotypes ?
• Which approach is best: population-level value vs personalized
medicine approach?
Several research priorities can be advocated:
• Follow the concept of integrative exposomics 102,103
• Develop bioinformatics approaches that link exposures with bio-
logical responses and disease outcomes. The exposome will be
represented as multifactorial variables. This will require sophisti-
cated informatics approaches
• Complex unifying models based on language standards for
exposures
• Guidelines for sample collection standards for use with emerging
and anticipated technologies
• Develop criteria for selecting the best assay(s) to assess the bio-
logical response for the research question of interest. These crite-
ria should be updated periodically to address emerging tools and
technologies.
5 | CONCLUDING REMARKS
The exposome concept offers a new and exciting paradigm for the
improvement and integration of currently scattered and uncertain
data on the impact of the environmental component on allergic dis-
ease inception and evolution. The designs/models of environmental
exposure should be assessed in longitudinal cohort studies of asthma
and allergic diseases and the assessment strategy adapted to the
population and cohort studies. Several challenges need to be
overcome such as how to prioritize and select the best tools and
outcomes and to standardize the timing and duration of measures. In
addition, it needs to be established if the exposure profile is suitable
for population and cohort studies.
Although many priority research needs and challenges related to
measurement harmonization remain, it is important to begin the
exposomic studies. While still formative, these studies assess the
feasibility of many new methods of exposure assessment, discovery
analysis, and data integration. Large‐scale initiatives test the validity
of exposure assessment in ways that smaller studies cannot. Switch-
ing from the “one‐exposure‐one‐health‐effect” approach to a more
holistic approach (Figure 4) to assess the environmental impact on
health and disease is essential to improve our understanding of the
predictors and risk and protective factors of complex, multifactorial,
chronic diseases, like asthma and allergic diseases. These develop-
ments will ultimately lead to better prevention strategies.
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